Aberrant protein aggregation in amyotrophic lateral sclerosis
Authors:
- 13 June 2024
- journal article
- review article
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (8) , 4826-4851
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal disease. As its pathological mechanisms are not well understood, there are no efficient therapeutics for it at present. While it is highly heterogenous both etiologically and clinically, it has a common salient hallmark, i.e., aberrant protein aggregation (APA). The upstream pathogenesis and the downstream effects of APA in ALS are sophisticated and the investigation of this pathology would be of consequence for understanding ALS. In this paper, the pathomechanism of APA in ALS and the candidate treatment strategies for it are discussed.Keywords
This publication has 328 references indexed in Scilit:
- Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Paraoxonase cluster polymorphisms are associated with sporadic ALSNeurology, 2006
- TDP-43 Binds Heterogeneous Nuclear Ribonucleoprotein A/B through Its C-terminal TailJournal of Biological Chemistry, 2005
- Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosisJournal of Cell Biology, 2005
- Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing proteinNature Genetics, 2004
- Munc13-1 is essential for fusion competence of glutamatergic synaptic vesiclesNature, 1999
- Slowing of axonal transport is a very early event in the toxicity of ALS–linked SOD1 mutants to motor neuronsNature Neuroscience, 1999
- Calcium‐permeable α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid receptors: A molecular determinant of selective vulnerability in amyotrophic lateral sclerosisAnnals of Neurology, 1997
- ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing InclusionsNeuron, 1997
- Parvalbumin and calbindin D‐28k in the human motor system and in motor neuron diseaseNeuropathology and Applied Neurobiology, 1993